Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02095678 · ClinicalTrials.gov registry record · NA
Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02095678 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 52 participants.
The verdict
NCT02095678, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The primary objective of this study is to develop and validate simultaneous free-breathing 4D fat and water quantification and quantitative dynamic contrast enhanced perfusion in the liver. Secondary aims include developing and validating free breathing quantification of relaxation parameters T1 and T2, and developing and validating a minimal breath-hold (\< 8 s) high quality diffusion exam using highly accelerated steady state diffusion imaging sequences. Investigators aim to scan 100 subjects receiving liver biopsies as a part of their standard care and another 70 subjects with known benign lesions. The study is greater than minimal risk.
Interventions
- PROCEDURE liver biopsy
- DEVICE free-breathing MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2019-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02095678
The ClinicalTrials.gov registry entry for NCT02095678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which liver biopsy is the first listed.
NCT02095678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02095678 about?
NCT02095678 is a clinical study titled "Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions". The primary objective of this study is to develop and validate simultaneous free-breathing 4D fat and water quantification and quantitative dynamic contrast enhanced perfusion in the liver. Secondary aims include developing and validating free breathing quantification of relaxation parameters T1 and...
What is the current status of trial NCT02095678?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2013-12-01. Estimated completion is 2019-12-03.
What interventions are being tested in trial NCT02095678?
The interventions under investigation include: liver biopsy (PROCEDURE), free-breathing MRI (DEVICE).
Who is sponsoring clinical trial NCT02095678?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.